Prosecution Insights
Last updated: November 04, 2026

Neuronexus Technologies Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Neuronexus Technologies Inc. manages 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is assigned to 1 distinct examiner in 1 distinct art unit. The portfolio's focus on 1 distinct art unit suggests a specialized application within the medical device field. With only 1 pending office action, the company has a singular point of contact at the USPTO, which simplifies the management of its intellectual property assets.

BRIAN MICHAEL ANTISKAY is the busiest examiner, handling 1 pending office action. This examiner is responsible for evaluating the technical claims in the company's only pending matter. Practitioners should prepare for a focused interaction with BRIAN MICHAEL ANTISKAY, as his interpretation of the prior art will be the primary factor in the case. The concentration of the workload under 1 distinct examiner ensures that the prosecution strategy remains consistent.

The presence of 1 pending office action indicates that the company is currently in a phase of targeted patent acquisition. By working within 1 distinct art unit, the legal team can tailor their arguments to the specific technical standards of the Medical Devices & Mechanical Engineering area. This streamlined prosecution profile allows for a high degree of attention to be paid to the active matter before the USPTO. BRIAN MICHAEL ANTISKAY holds the key to the company's immediate success in this technology area.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ANTISKAY, BRIAN MICHAEL 1 67.3% +39.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18384628 Neurotrophic Electrode Array ANTISKAY, BRIAN MICHAEL —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18384628 Neurotrophic Electrode Array ANTISKAY, BRIAN MICHAEL —

Top Art Units

Art UnitApps
3794 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18384628 Neurotrophic Electrode Array ANTISKAY, BRIAN MICHAEL 3794 §103§112 Final Rejection — Pending Oct 27, 2023

Managing Neuronexus Technologies Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Neuronexus Technologies Inc. have?

Neuronexus Technologies Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Neuronexus Technologies Inc. applications?

Brian Michael Antiskay has the most, with 1 of Neuronexus Technologies Inc.'s pending office actions.

What technology area are Neuronexus Technologies Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month